The Aroon Indicator for ASLE entered a downward trend on October 14, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 190 similar instances where the Aroon Indicator formed such a pattern. In 158 of the 190 cases the stock moved lower. This puts the odds of a downward move at 83%.
The Momentum Indicator moved below the 0 level on September 25, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ASLE as a result. In 61 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.
The Moving Average Convergence Divergence Histogram (MACD) for ASLE turned negative on September 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 35 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 80%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ASLE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +4.96% 3-day Advance, the price is estimated to grow further. Considering data from situations where ASLE advanced for three days, in 214 of 298 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
ASLE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 58 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.606) is normal, around the industry mean (142.182). ASLE has a moderately high P/E Ratio (30.619) as compared to the industry average of (14.484). Projected Growth (PEG Ratio) (0.100) is also within normal values, averaging (0.572). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (0.846) is also within normal values, averaging (7.125).
The Tickeron Price Growth Rating for this company is 80 (best 1 - 100 worst), indicating slightly worse than average price growth. ASLE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 84 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ASLE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock worse than average.
SRTA saw its Momentum Indicator move below the 0 level on September 28, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 73 similar instances where the indicator turned negative. In 66 of the 73 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for SRTA turned negative on September 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 39 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 80%.
The 10-day moving average for SRTA crossed bearishly below the 50-day moving average on September 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 78%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SRTA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
The Aroon Indicator for SRTA entered a downward trend on October 08, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +1.57% 3-day Advance, the price is estimated to grow further. Considering data from situations where SRTA advanced for three days, in 205 of 251 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
SRTA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 54 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 77 (best 1 - 100 worst), indicating slightly worse than average price growth. SRTA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 96 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.656) is normal, around the industry mean (208.195). SRTA's P/E Ratio (2375.680) is considerably higher than the industry average of (175.456). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (1.730) is also within normal values, averaging (2.688).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SRTA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
ASLE | SRTA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 77 | 60 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 58 Fair valued | 96 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 91 | 54 | |
PRICE GROWTH RATING 1..100 | 80 | 77 | |
P/E GROWTH RATING 1..100 | 84 | 2 | |
SEASONALITY SCORE 1..100 | 6 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ASLE's Valuation (58) in the null industry is somewhat better than the same rating for SRTA (96). This means that ASLE’s stock grew somewhat faster than SRTA’s over the last 12 months.
ASLE's Profit vs Risk Rating (100) in the null industry is in the same range as SRTA (100). This means that ASLE’s stock grew similarly to SRTA’s over the last 12 months.
SRTA's SMR Rating (54) in the null industry is somewhat better than the same rating for ASLE (91). This means that SRTA’s stock grew somewhat faster than ASLE’s over the last 12 months.
SRTA's Price Growth Rating (77) in the null industry is in the same range as ASLE (80). This means that SRTA’s stock grew similarly to ASLE’s over the last 12 months.
SRTA's P/E Growth Rating (2) in the null industry is significantly better than the same rating for ASLE (84). This means that SRTA’s stock grew significantly faster than ASLE’s over the last 12 months.
| ASLE | SRTA | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 76% | 2 days ago 88% |
| Stochastic ODDS (%) | 2 days ago 70% | 2 days ago 85% |
| Momentum ODDS (%) | 2 days ago 78% | 2 days ago 90% |
| MACD ODDS (%) | 2 days ago 80% | 2 days ago 80% |
| TrendWeek ODDS (%) | 2 days ago 80% | 2 days ago 83% |
| TrendMonth ODDS (%) | 2 days ago 80% | 2 days ago 81% |
| Advances ODDS (%) | 8 days ago 72% | 5 days ago 82% |
| Declines ODDS (%) | 3 days ago 76% | 3 days ago 85% |
| BollingerBands ODDS (%) | 2 days ago 68% | 2 days ago 80% |
| Aroon ODDS (%) | 2 days ago 83% | 2 days ago 73% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ASLE’s FA Score shows that 0 FA rating(s) are green while SRTA’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ASLE’s TA Score shows that 4 TA indicator(s) are bullish while SRTA’s TA Score has 4 bullish TA indicator(s).
ASLE (@Air Freight/Couriers) experienced а -4.67% price change this week, while SRTA (@Hospital/Nursing Management) price change was -2.91% for the same time period.
The average weekly price growth across all stocks in the @Air Freight/Couriers industry was -8.28%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -32.64%.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -0.81%. For the same industry, the average monthly price growth was -7.16%, and the average quarterly price growth was +16.84%.
ASLE is expected to report earnings on Nov 10, 2026.
SRTA is expected to report earnings on Nov 11, 2026.
The Air Freight/Couriers industry operates air transportation and recurring delivery services. This includes companies offering same-day deliveries, scheduled delivery and logistical services. The proliferation of e-commerce/online retail with a growing emphasis on faster delivery has expanded opportunities for this industry, and induced more competition. United Parcel Service, Inc., FedEx Corporation and Expeditors International of Washington, Inc. are some of the major companies in this industry.
@Hospital/Nursing Management (-0.81% weekly)Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
A.I.dvisor tells us that ASLE and CAAP have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ASLE and CAAP's prices will move in lockstep.
| Ticker / NAME | Correlation To ASLE | 1D Price Change % | ||
|---|---|---|---|---|
| ASLE | 100% | +0.21% | ||
| CAAP - ASLE | 23% Poorly correlated | +2.49% | ||
| ASR - ASLE | 22% Poorly correlated | +2.17% | ||
| PAC - ASLE | 19% Poorly correlated | +2.88% | ||
| SRTA - ASLE | 16% Poorly correlated | +1.40% | ||
| OMAB - ASLE | 9% Poorly correlated | +2.91% | ||
More | ||||
A.I.dvisor indicates that over the last year, SRTA has been loosely correlated with JOBY. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if SRTA jumps, then JOBY could also see price increases.
| Ticker / NAME | Correlation To SRTA | 1D Price Change % | ||
|---|---|---|---|---|
| SRTA | 100% | +1.40% | ||
| JOBY - SRTA | 57% Loosely correlated | +4.34% | ||
| UP - SRTA | 36% Loosely correlated | +10.94% | ||
| AIRS - SRTA | 26% Poorly correlated | -0.35% | ||
| STLN - SRTA | 26% Poorly correlated | +6.14% | ||
| JYNT - SRTA | 24% Poorly correlated | +0.14% | ||
More | ||||